Find clinical trials for Eczema in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near Phoenix, AZ, USA:
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema...
Phase 2
Phoenix, Arizona, United States and 35 other locations
This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety...
Phase 2
Phoenix, Arizona, United States and 26 other locations
The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...
Phase 3
Phoenix, Arizona, United States and 41 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Phoenix, Arizona, United States and 179 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Gilbert, Arizona, United States and 83 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Phoenix, Arizona, United States and 97 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Phoenix, Arizona, United States and 95 other locations
Global Assessment for Atopic Dermatitis (vIGA-AD).* Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema...
Phase 3
Scottsdale, Arizona, United States and 196 other locations
/TCI, compared with placebo in combination with TCS/TCI at Week 24, assessed using Eczema Area and Severity Index (EASI)....
Phase 3
Phoenix, Arizona, United States and 234 other locations
The study is designed to evaluate the long-term safety and efficacy of GSK1070806 in participants with moderate-to severe atopic dermatitis, who have...
Phase 2
Phoenix, Arizona, United States and 90 other locations
Clinical trials
Research sites
Resources
Legal